e-learning
resources
Virtual 2020
Sunday, 06.09.2020
Impact in children and in adults with premorbid respiratory disease (acute and long-term)
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Airways disease
G. Brusselle (Ghent, Belgium)
Source:
Virtual Congress 2020 – Impact in children and in adults with premorbid respiratory disease (acute and long-term)
Session:
Impact in children and in adults with premorbid respiratory disease (acute and long-term)
Session type:
COVID-19
Number:
3646
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Brusselle (Ghent, Belgium). Airways disease. Virtual Congress 2020 – Impact in children and in adults with premorbid respiratory disease (acute and long-term)
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Airways diseases I
Source: ERS Course 2015
Year: 2015
Airways diseases I
Source: HERMES Summer School 2014 - Educational material
Year: 2014
Airways diseases II
Source: ERS Course 2015
Year: 2015
Airways diseases II
Source: HERMES Summer School 2014 - Educational material
Year: 2014
CT of the Airways
Source: Eur Respir Rev 2011; 20: 65
Year: 2011
Airways infections in patients with interstitial lung diseases
Source: Annual Congress 2009 - Cell biology of lung disease
Year: 2009
Inflammatory airway diseases and clinical allergy: Inflammatory Airways Diseases and Clinical Allergy Assembly contribution to the celebration of 20 years of the ERS
Source: Eur Respir J 2010; 35: 1197-1199
Year: 2010
Scleroderma lung disease
Source: Eur Respir Rev 2013; 22: 6-19
Year: 2013
Small Airways Disease and Emphysema (Assessed by High-Resolution CT) and Symptom Burden in COPD
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021
Late Breaking Abstract - Small Airways Dysfunction (SAD) correlates with relevant asthma outcomes: longitudinal results from the AssessmenT of smalL Airways involvemeNT In aSthma (ATLANTIS) Study
Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Year: 2020
Clinical presentation of chronic obstructive pulmonary disease (COPD): Study on-sint
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014
Cardiovascular disease in COPD
Source: Eur Respir Monogr 2020; 88: 47-65
Year: 2020
Role of antibiotics in exacerbations of chronic obstructive pulmonary disease: a Cochrane review
Source: Annual Congress 2006 - COPD and inflammation
Year: 2006
Airways mucus pathogenesis in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2018 – Biomarkers and lung function in airway disease
Year: 2018
Asthma and smoking-induced airway disease without spirometric COPD
Source: Eur Respir J, 49 (5) 1602061; 10.1183/13993003.02061-2016
Year: 2017
Chronic obstructive pulmonary disease (COPD) and alterations of hemogram
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Clinical factors linked with coronary artery disease in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
The metabolic syndrome in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept